Platelet activation via trimeric GTP-binding proteins.
Akkerman
J W
JW
Dept. of Haematology, University Hospital Utrecht, The Netherlands.
van Willigen
G
G
D002118:Calcium / Q000502:physiology; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000502:physiology; D000242:Cyclic AMP / Q000502:physiology; D011464:Epoprostenol / Q000502:physiology; D019204:GTP-Binding Proteins / Q000737:chemistry / Q000502:physiology*; D006160:Guanosine Triphosphate / Q000502:physiology; D006801:Humans; D010741:Phospholipases A / Q000502:physiology; D015539:Platelet Activation / Q000187:drug effects / Q000502:physiology*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D010980:Platelet Membrane Glycoproteins / Q000502:physiology; D011487:Protein Conformation; D015398:Signal Transduction / Q000502:physiology*; D013928:Thromboxane A2 / Q000502:physiology; D010738:Type C Phospholipases / Q000502:physiology
D010975:Platelet Aggregation Inhibitors; D010980:Platelet Membrane Glycoproteins; D013928:Thromboxane A2; D006160:Guanosine Triphosphate; D011464:Epoprostenol; D000242:Cyclic AMP; D017871:Calcium-Calmodulin-Dependent Protein Kinases; D010741:Phospholipases A; D010738:Type C Phospholipases; D019204:GTP-Binding Proteins; D002118:Calcium